Patterns of DNA ploidy and S-phase fraction associated with breast cancer survival in blacks and whites

Clinical Cancer Research

Volumn 3, Issue 4, 1997, Pages 587-592

  Shiao, Yih Horng ^a   Chen, Vivien W ^b   Peter Lehmann, H ^b   Wu, Xiao Cheng ^b   Correa, Pelayo ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; SURVIVAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CELL CYCLE; DIPLOIDY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOUISIANA; MIDDLE AGED; NEOPLASM STAGING; PLOIDIES; POLYPLOIDY; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; S PHASE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0030988804     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. National Cancer Institute. Cancer among Blacks and Other Minorities: Statistical Profiles. NIH Publ. No. 86-2785: Washington, DC, 1986.
2. Miller, B. A., Ries, L. A. G., Hankey, B. F., Kosary, C. L., and Edwards, B. K. Cancer Statistics Review: 1973-1989. National Cancer Institute, NIH Publ. No. 92-2789, 1992.
3. Berg, J. W., RUSS, R., and Latourette, H. B. Economic status and survival of cancer patients. Cancer (Phila.), 39: 467-477, 1977.
4. Bassett, M. T., and Krieger, N. Social class and black-white differences in breast cancer survival. Am. J. Public Health, 76: 1400-1403, 1986.
5. McWhorter, W. P., and Mayer, W. J. Black/white differences in type of initial breast cancer treatment and implications of survival. Am. J. Public Health, 77: 1515-1517, 1977.
6. Chen, V. W., Correa, P., Kurman, R. J., Wu, X. C., Eley, J. W., Austin, D., Muss, H., Hunter, C., Redmond, C., Sobhan, M., Coates, R., Reynolds, P., Herman, A. A., and Edwards, B. K. Histologic characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol., Biomarkers & Prev., 3: 127-135, 1994.
7. Eley, J. W., Hill, H. A., Chen, V. W., Austin, D. F., Wesley, M. N., Muss, H. B., Greenberg, R. S., Coates, R. J., Correa, P., Blacklow R., Shapiro, S., and Edwards, B. K. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. J. Am. Med. Assoc., 272: 947-954, 1994.
8. Spyratos, F. DNA content and cell cycle analysis by flow cytometry in clinical samples: application in breast cancer. Biol. Cell, 78: 69-72, 1993.
9. Clark, G. M., Dressier, L. G., Owens, M. A., Pounds, G., Oldaker, T., and McGuire, W. L. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N. Engl. J. Med., 320: 627-633, 1989.
10. Toikkanen, S., Joensuu, H., and Klemi, P. The prognostic significance of nuclear DNA content in invasive breast cancer - a study with long-term follow-up. Br. J. Cancer, 60: 693-700, 1989.
11. Beerman, H., Kluin, P. M., Hermans, J., van De Velde, C. J. H., and Cornelisse, C. J. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Int. J. Cancer, 45: 34-39, 1990.
12. Fisher, B., Gunduz, N., Costantino, J., Fisher, E. R., Redmond, C., Mamounas, E. P., and Siderits, R. DNA flow cytometric analysis of primary operable breast cancer. Cancer (Phila.), 68: 1465-1475, 1991.
13. Hedley, D. W., Clark, G. M., Cornelisse, C. J., Killander, D., Kute, T., and Merkel, D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry, 14: 482-485, 1993.
14. Witzig, T. E., Ingle, J. N., Cha, S. S., Schaid, D. J., Tabery, R. L., Wold, L. E., Grant, C., Gonchoroff, N. J., and Katzmann, J. A. DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer. Cancer (Phila.), 74: 1752-1761, 1994.
15. Fernö, M., Baldetorp, B., Borg, Å., Olsson, H., Sigurdsson, H., and Killander, D. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncol., 31: 157-165, 1992.
16. Balslev, I., Christensen, I. J., Bruun Rasmussen, B., Larsen, J. K., Lykkesfeldt, A. E., Thorpe, S. M., et al. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer. Int. J. Cancer, 56: 16-25, 1994.
17. Stål, O., Dufmats, M., Hatschek, T., Carstensen, J., Klintenberg, C., Rutqvist, L. E., Skoog, L., Sullivan, S., Wingren, S., and Nordenskjöld, B. S-phase fraction is a prognostic factor in stage I breast carcinoma. J. Clin. Oncol., 11: 1717-1722, 1993.
18. Merkel, D. E., Winchester, D. J., Goldschmidt, R. A., August, C. Z., Wruck, D. M., and Rademaker, A. W. DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer. Cancer (Phila.), 72: 1926-1932, 1993.
19. Howard, J., Hankey, B. F., Greenberg, R. S., Austin, D. F., Correa, P., Chen, V. W., and Durako, S. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer (Phila.), 69: 2349-2360, 1992.
20. Shiao, Y. H., Chen, V. W., Scheer, W. D., Wu, X. C., and Correa, P. Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res., 55: 1485-1490, 1995.
21. Heiden, T., Wang, N., and Tribukait, B. An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry, 12: 614-621, 1991.
22. Kallioniemi, O-P., Visakorpi, T., Holli, K., Isola, J. J., and Rabinovitch, P. S. Automated peak detection and cell cycle analysis of flow cytometric DNA histograms. Cytometry, 16: 250-255, 1994.
23. Shankey, T. V., Rabinovitch, P. S., Bagwell, B., Bauer, K. D., Duque, R. E., Hedley, D. W., Mayall, B. H., and Wheeless, L. Guidelines for implementation of clinical DNA cytometry. Cytometry, 14: 472-477, 1993.
24. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete data. J. Am. Stat. Assoc., 54: 457-481, 1958.
25. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
26. Cox, D. R. Regression models and life tables. J. R Stat. Soc., 34: 187-220, 1972.
27. Elledge, R. M., Clark, G. M., Chamness, G. C., and Osborne, C. K. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J. Natl. Cancer Inst., 86: 705-712, 1994.
28. Bonadonna, G., Valagussa, P., Tancini, G., Rossi, A., Brambilia, C., Zambetti, M., Bignami, P., Fronzo, G., and Silvestrini, R. Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer. Natl. Cancer Inst. Monogr., 1: 45-49, 1986.
29. Remvikos, Y., Beuzeboc, P., Zajdela, A., Voillemot, N., Magdelenat, H., and Pouillart P. Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J. Natl. Cancer Inst., 81: 1383-1387, 1989.
30. Klijn, J. G., Berns, E. M., and Foekens, J. Prognostic factors and response to therapy in breast cancer. Cancer Surv., 18: 165-198, 1993.
31. Kimmick, G., Muss, H. B., Case, L. D., and Stanley, V. A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer. Cancer (Phila.), 67: 2850-2854, 1991.